Provided by Tiger Trade Technology Pte. Ltd.

ADiTx Therapeutics

2.48
-0.3300-11.74%
Post-market: 2.480.00000.00%17:41 EST
Volume:563.84K
Turnover:1.41M
Market Cap:1.39M
PE:0.00
High:2.69
Open:2.68
Low:2.36
Close:2.81
52wk High:10,452.50
52wk Low:2.36
Shares:559.40K
Float Shares:559.40K
Volume Ratio:0.09
T/O Rate:100.79%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4,919.3423
EPS(LYR):-346,053.3627
ROE:-282.21%
ROA:-61.70%
PB:-0.18
PE(LYR):0.00

Loading ...

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:47 AM

Reuters
·
Dec 01

Top Premarket Decliners

MT Newswires Live
·
Dec 01

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:50 AM

Reuters
·
Nov 28

Top Premarket Gainers

MT Newswires Live
·
Nov 28

Chief M&A Officer Corinne Pankovcin Reports Sale of ADiTx Inc. Common Shares

Reuters
·
Nov 27

BRIEF-Aditxt Provides Updates On Its Growth Vision For Bitxbio™, Planned Digital Asset Treasury, Pearsanta’S Planned IPO, And Evofem’S Plan To Regain A National Listing

Reuters
·
Nov 18

Aditxt Inc. Seeks Shareholder Approval for Name Change to bitXbio, Employee Stock Purchase Plan in Upcoming Proxy Vote

Reuters
·
Nov 18

Aditxt Provides Updates on Its Growth Vision for Bitxbio™, Planned Digital Asset Treasury, Pearsanta’s Planned IPO, and Evofem’s Plan to Regain a National Listing

THOMSON REUTERS
·
Nov 18

ADiTx Inc. Delays Filing of Quarterly Report

Reuters
·
Nov 17

ADiTx Inc. Announces Date for Upcoming Special Meeting of Stockholders

Reuters
·
Nov 15

ADiTx Therapeutics trading halted, news pending

TIPRANKS
·
Nov 01

ADiTx Enacts 1-for-113 Reverse Stock Split

Reuters
·
Oct 30

Aditxt, Inc. (Nasdaq: Adtx) Announces 1-for-113 Reverse Stock Split Effective at the Open of Trading on November 3, 2025

THOMSON REUTERS
·
Oct 30

Aditxt Says Pearsanta Unit Begins Enrollment in Study of Test to Detect Endometriosis

MT Newswires Live
·
Oct 27

Aditxt Subsidiary Pearsanta Begins Enrollment in First Human Study of Blood-Based Diagnostic for Endometriosis, a Condition Affecting 190 Million Women Worldwide and Representing a $1.45 Billion Global Market

THOMSON REUTERS
·
Oct 27

Evofem Biosciences Inc: Delivered Notice of Termination to Aditxt Notifying That Co Was Exercising Its Right to Terminate Merger Agreement

THOMSON REUTERS
·
Oct 21

Press Release: Evofem Announces Voting Results from Special Meeting of Stockholders

Dow Jones
·
Oct 21

ADiTx Inc. Files Initial Statement of Beneficial Ownership for Christopher Jon Porcelli, General Counsel, CPO & CS

Reuters
·
Oct 03

ADiTx Inc. Files Initial Statement of Beneficial Ownership for Director Sylvia Hermina

Reuters
·
Sep 30

ADiTx Inc. Held Annual Meeting of Stockholders

Reuters
·
Sep 25